Co-Authors
This is a "connection" page, showing publications co-authored by Pierluigi Viale and Maria Re.
Connection Strength
2.158
-
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. J Acquir Immune Defic Syndr. 2021 01 01; 86(1):e15-e17.
Score: 0.230
-
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. New Microbiol. 2019 Jul; 42(3):145-149.
Score: 0.208
-
In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2019 05 01; 74(5):1457-1459.
Score: 0.205
-
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study. J Antimicrob Chemother. 2018 10 01; 73(10):2856-2859.
Score: 0.197
-
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia. HIV Clin Trials. 2018 06; 19(3):120-128.
Score: 0.193
-
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy. Infect Dis (Lond). 2018 05; 50(5):352-360.
Score: 0.186
-
Characterization of an IncL/M plasmid carrying blaOXA-48 in a Klebsiella pneumoniae strain from Italy. New Microbiol. 2017 Oct; 40(4):284-285.
Score: 0.184
-
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
Score: 0.181
-
Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS. 2017 03 13; 31(5):681-688.
Score: 0.177
-
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients. Curr HIV Res. 2017; 15(6):448-455.
Score: 0.175
-
The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol. 2021; 11:670424.
Score: 0.060
-
The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021 05 12; 11(1):10103.
Score: 0.059
-
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations. J Glob Antimicrob Resist. 2021 03; 24:124-126.
Score: 0.058
-
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates. Int J Infect Dis. 2017 Dec; 65:1-3.
Score: 0.046